Patient-Centered Adherence Intervention After Acute Coronary Syndrome (ACS) Hospitalization
Acute Coronary Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT00903032 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Intervention (Behavioral); Usual care (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- US Department of Veterans Affairs
- Primary completion
- Mar 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Cardioprotective Medications (Clopidogrel, Statins, Beta Blockers, ACE-inhibitor/ARB) |
89.3; 73.9 | 0.003 sig |
Summary
Eligibility Criteria
Inclusion Criteria
All patients admitted with acute coronary syndrome (ACS) as the primary reason for hospital admission and use the VA for their usual source of care, defined as having 1 primary care visit within the 12 months prior to hospital admission will be screened for eligibility to participate. ACS is defined as acute myocardial infarction (both ST-elevation MI and non-ST elevation MI) or unstable angina. The presence of acute myocardial infarction will be defined using standard definitions from an international consensus statement, based on the following: a rise and/or fall of cardiac biomarkers (preferably troponin) with at least one value above the 99th percentile of the upper reference limit and at least one of the following:
- symptoms of ischemia;
- ECG change indicative of new ischemia (new ST-T changes or new left bundle branch block);
- development of pathological Q waves in the ECG; or
- imaging evidence of new loss of viable myocardium or new regional wall motion abnormality.42 Unstable angina will be defined by presence of ischemic symptoms and ECG changes indicative of new ischemia but without biomarker evidence of myonecrosis (i.e., biomarker elevation) and no evidence of new pathological Q waves, loss of viable myocardium or regional wall motion abnormality.
Exclusion Criteria
- Patient admitted for primary non-cardiac diagnosis and develop ACS as a secondary condition (e.g. perioperative MI);
- planned discharge to nursing home or skilled nursing facility;
- irreversible, non-cardiac medical condition (e.g. metastatic cancer) likely to affect 6-month survival or ability to execute study protocol;
- lack of telephone/cell phone;
- VA is not primary source of care;
- regularly fill medications at non-VA pharmacy.
Data sourced from ClinicalTrials.gov (NCT00903032). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.